As shown in Figure 6A and 6B, the EphA2-silenced oxaliplatin-resistant gastric cancer cells (SGC-7901/L-OHP) migrated at a significantly reduced rate compared with the control group (P < 0.05). The gene discussed is EPHA2; the disease is gastric cancer.